MiR-572 prompted cell proliferation of human ovarian cancer cells by suppressing PPP2R2C expression

Biomed Pharmacother. 2016 Feb:77:92-7. doi: 10.1016/j.biopha.2015.12.005. Epub 2015 Dec 28.

Abstract

Ovarian cancer (OC) remains one of the most common types of malignant cancer, and the molecular mechanism underlying its proliferation is still largely unclear. It is reported that microRNAs acted as important regulators of cell proliferation by regulating its targeted gene. In this study, our result showed that miR-572 was markedly upregulated in OC cell lines and clinical tissues. Results of both gain-of-function and loss-of-function experiments revealed that upregulation of miR-572 expression dramatically promoted OC cell proliferation, whereas decreased miR-572 expression significantly reduced cell proliferation. Bioinformatics analysis and luciferase reporter assays further revealed PPP2R2C, a putative tumor suppressor as a potential target of miR-572. Moreover, silencing of PPP2R2C using small interfering RNA (siRNA) counteracted the proliferation arrest by miR-572-in in OC cells. In sum, our data provide that miR-572 promoted cell proliferation in OC by targeting PPP2R2C and might serve as a therapeutic target of OC.

Keywords: Cell proliferation; Ovarian cancer; PPP2R2C; miR-572.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • Cell Proliferation
  • Female
  • Gene Expression Regulation, Neoplastic
  • Humans
  • MicroRNAs / genetics*
  • Ovarian Neoplasms / genetics*
  • Protein Phosphatase 2 / genetics*
  • Real-Time Polymerase Chain Reaction

Substances

  • MIRN-572 microRNA, human
  • MicroRNAs
  • PPP2R2C protein, human
  • Protein Phosphatase 2